Breaking News

FDA lifts partial clinical hold for GMP deficiencies

The US FDA has lifted partial clinical hold on Innate Pharma's Lacutamab Tellomak trial in advanced T cell lymphomas

ViralClear partners with CDMO on potential COVID-19 treatment Merimepodib

ViralClear Pharmaceuticals has partnered with Albany Molecular Research Inc (AMRI) on the manufacture of Merimepodib ...

Cambridge Uni spin-out raises $2.25m to transition to drug development

The 2016 spin-out PharmEnable's technology can predict improved small molecule hits to targets across a range of ...

Optimising gene therapy for now and the future

With multiple gene therapies currently approved for use in the US, dozens in pivotal trials and hundreds more in ...

Equivir shows prophylactic COVID-19 results in independent testing

Impact Biomedical has announced in vitro success with Equivir and 3F Biofragrance against COVID-19 in independent ...

Lonza aims to tackle bias concerns during blinded clinical trials

Lonza has introduced an over-encapsulation product aimed at tackling concerns around bias during blinded clinical trials

Accelerating vaccine development with AI

Despite the tremendous advances in medical science in recent decades, there is still so much about the human body that ...

Automation in pharmaceutical manufacturing

Automating drug discovery increases accuracy, precision and reproducibility

Adapt and succeed in challenging times

How UK labs are adapting to new working conditions

Reducing time-to-market with innovative approaches to analytical services

The way in which drug developers approach analytical chemistry can be crucial in terms of driving efficiencies in ...

Tackling coronavirus with AI-derived combination drug products: Part I

The ongoing spread of COVID-19 is risking the lives of millions of rare disease patients around the world. Dr David ...

Getting it right: best practices for analytical method transfers

In a highly regulated environment, the laboratory that develops and validates an analytical method does not necessarily ...

Collaborating in the fight against COVID-19

The founder of Apple, Steve Jobs, once said: “Great things in business are never done by one person; they’re done ...

PCI and Experic announce strategic drug supply chain collaboration

Complementary technologies and capabilities add value and drive growth for both companies